CPhI Worldwide 2013 hosted more than 34,000 global pharma professionals
with expanded content and first Annual Report
This year sees strong growth in APIs, biopharma, natural extracts,
packaging and finished dosage with a highlight on innovation
AMSTERDAM, Nov. 21, 2013 /CNW/ - CPhI Worldwide, organised by UBM Live, celebrates the closing of its most successful
show to date with pre-audit figures estimating more than 34,000
attendees and 2,200 exhibitors. Held in Frankfurt, the show hosted
senior-level decision makers and key players from 140+ countries
representing every step of the pharmaceutical supply chain from drug
discovery to finished dosage.
(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )
To view the Multimedia News Release, please click:
On Monday, CPhI Conferences hosted the Pre-Connect with six modules on
themes including drug delivery systems and biosimilars. The conference
featured senior executives and influential industry speakers from
Bayer, Novartis and Wockhardt, who leveraged their expertise and
insight to educate the industry. Throughout the week, free content was
available in the exhibition with sessions covering Ingredients,
Contract Services, Packaging, Animal Health, Biopharma and Natural
Extracts, Innovation Tours on biopharma and packaging, and Lunch
Briefings on emerging markets of India and Brazil.
With four different exhibitions in one (CPhI, P-MEC, InnoPack and ICSE)
the event has become the world's melting pot and key point of the year
to complete new deals, see innovative technologies and meet potential
partners - attendees say it's invaluable to the industry. This year's
event held a record of 17 global pavilions to highlight different
countries from each continent - including China, India, USA and Brazil
The winners of the 2013 CPhI Pharma Awards were announced, honouring
innovation across three categories (Best Innovation in Formulation,
Packaging and Process Development) which went to Camurus, E-Pharma
Trento and API Corporation, respectively.
Another major addition to this year's show was the introduction of CPhI
Pharma Evolution - a new community website launched in February to help
professionals from the pharma industry to share advice from their peers
on best-practices and regulatory changes across the pharmaceutical
ingredient and contract manufacturing space. The site features a wealth
of stories covering the huge amounts of activity across all four days
of the show, including news on all the major initiatives and company
news announced. For more information, please visit: http://www.pharmaevolution.com/.
CPhI Worldwide and CPhI Pharma Evolution were pleased to release its
first Annual Report during the event. Written by a panel of industry
experts, the report highlighted key trends including QbD, PAT and six
sigma in a series of forward-looking articles.
Chris Kilbee, Group Director of CPhI, commented: "This year's event has
been a great success with exhibitors reporting quality meetings and
promising business opportunities coming out of the event. We're pleased
to expand our content offering this year with seminars, innovation
tours and the release of the first Annual Report. As the pharmaceutical
market continues to grow and expand, CPhI will adapt and evolve to
deliver industry insights and continue to provide the best platform for
developing contacts as the event returns to Paris for its 25th edition
from 7-9 October 2014."
Notes to editors
About CPhI Pharma Evolution annual report and expert industry panel
Earlier this year, CPhI launched a major new initiative with the
introduction of its annual report published in cooperation with Pharma
Evolution - written by a panel of world-leading experts across the
pharmaceutical supply chain.
The vision was to harness the power of CPhI's independent position
within the industry so that it could produce unbiased analysis of the
global pharmaceutical industry and help bring different perspectives
The annual report utilises expert in-depth essays, looking at future
contingencies. Experts were given carte blanche to evaluate current
industry practices and examine the future implications for the
CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global market.
CPhI hosts events in Europe, China, India, Japan, Southeast Asia,
Russia and South America co-located with ICSE for contract services,
P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an
online buyer & supplier directory at CPhI-Online.com and hosts a global community with news and analysis at PharmaEvolution.com.
For more information visit: http://www.cphi.com
The UBM Live annual schedule of Pharmaceutical events also includes CPhI
and P-MEC India (3-5 December, 2013 at the Bombay Exhibition Centre in
Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014
in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 in St Petersburg,
Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014 in
Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI,
Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at
SNIEC, Shanghai, China), CPhI South America (5-7 August 2014 at Expo
Centre Norte, Sao Paulo- Brazil); CPhI Worldwide, ICSE, P-MEC Europe
and InnoPack (7-9 October, 2014 at Paris Nord Villepintei, Paris-
About CPhI Pharma Evolution
CPhI Pharma Evolution (http://www.pharmaevolution.com) launched in February 2013 as a global online community where
professionals from across the pharmaceutical manufacturing sector can
talk with their peers and share best-practices and regulatory updates
across the pharmaceutical ingredient and contract manufacturing space.
Pharma Evolution is the new go-to community for industry professionals
to exchange thoughts and network on key areas including: formulation,
APIs, excipients, drug delivery, R&D, manufacturing and quality,
packaging and anti-counterfeiting, regulatory compliance, and
outsourcing and supply chain management. Pharma Evolution was created
as an extension of CPhI's global events business as a forum and
resource for pharmaceutical executives to employ 365 days a year.
Pharma Evolution is published by CPhI and UBM DeusM (http://www.deusm.com), the marketing services division of UBM specializing in building and
operating highly engaged communities of qualified users within
specialist B2B markets, using a strategy of best-practices focused on
content and technology.
About UBM Live
UBM Live connects people and creates opportunities for companies across
five continents to develop new business, meet customers, launch new
products, promote their brands, and expand their market. Through
premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise
Shipping Miami, the Concrete Show, and many others, UBM Live
exhibitions, conferences, awards programs, publications, Websites, and
training and certification programs are an integral part of the
marketing plans of companies across more than 20 industry sectors.
SOURCE: UBM Live
For further information:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745 / 6740
E: email@example.com / firstname.lastname@example.org